Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Tanja, C Stam"'
1
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer
Autor: Cornelis D. de Kroon, Annerie Slot, Jannet C. Beukema, Tanja C. Stam, Judith R. Kroep, Hetty A. van den Berg, Ina M. Jürgenliemk-Schulz, Cathalijne C.B. Post, Jan Willem M. Mens, Ludy C.H.W. Lutgens, F. Koppe, Marie A.D. Haverkort, Ellen M.A. Roeloffzen, An Snyers, Carien L. Creutzberg, Eva E. Schaake, Anne M. Stiggelbout, Hans W. Nijman
Publikováno v: Gynecologic Oncology, 161(3), 727-733
Gynecologic Oncology, 161(3), 727-733. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(3), 727-733. Academic Press
Gynecologic Oncology, 161, 727-733
Gynecologic Oncology, 161(3), 727-733. Elsevier Science
Gynecologic Oncology, 161, 3, pp. 727-733
Background. Decision making regarding adjuvant therapy for high-risk endometrial cancer is complex. The aim of this study was to determine patients' and clinicians' minimally desired survival benefit to choose chemoradiotherapy over radiotherapy alon
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77770acfb71df561bcba551f557aa5cc
https://doi.org/10.1016/j.ygyno.2021.03.004
Zobrazit plný text záznamu
2
PORTEC-4a
Autor: Nanda Horeweg, Stefan Kommoss, Ludy C.H.W. Lutgens, Katrien Vandecasteele, Marlies E. Nowee, Remi A. Nout, C. Gillham, Bastiaan G Wortman, F. Koppe, Hetty A. van den Berg, Tjalling Bosse, David Cibula, Karen W Verhoeven-Adema, Annerie Slot, Hein Putter, Cyrus Chargari, Ina M. Jürgenliemk-Schulz, Veronique L M A Coen, Aleida G Zwanenburg, Hans W. Nijman, Carien L. Creutzberg, Elzbieta van der Steen-Banasik, Tanja C. Stam, G Henrieke Westerveld, Anne Sophie V M van den Heerik, Wilbert B. van den Hout, Jan Willem M. Mens, An Snyers, Moritz Hamann, Stefan Bijmolt
Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020(30), 2002-2007. BMJ Publishing Group
International journal of gynecological cancer, 30(12), 2002-2007. Wolters Kluwer Health
International Journal of Gynecological Cancer, 30, 12, pp. 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. BMJ Publishing Group
International Journal of Gynecological Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
International Journal of Gynecological Cancer, 30, 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. LIPPINCOTT WILLIAMS & WILKINS
BackgroundVaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited impact on quality of life. However, t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57344841d5afbe302a24fc27474aae68
https://doi.org/10.1136/ijgc-2020-001929
Zobrazit plný text záznamu
3
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Autor: Carien L. Creutzberg, Petronella B. Ottevanger, Annamaria Ferrero, Luis Souhami, Pearly Khaw, GH Westerveld, Diane Provencher, Gillian Thomas, Jan Pyman, V. Do, Annerie Slot, C Davidson, G. Wilson, Stephanie M. de Boer, Peter Hoskin, C M McLachlin, Michael A. Quinn, Deborah Gregory, Remi A. Nout, Hans W. Nijman, J.J. Jobsen, Tanja C. Stam, Vincent T.H.B.M. Smit, K Whitmarsh, Paul Bessette, Roy F.P.M. Kruitwagen, W Taylor, Dionyssios Katsaros, Chantal Hanzen, Henry C Kitchener, M McCormack, Prafull Ghatage, Dominique Berton-Rigaud, J.W.M. Mens, Melanie E Powell, Elisabeth Pras, Jonathan A. Ledermann, Karen W Verhoeven-Adema, Harmen Hollema, Andrea Lissoni, Linda Mileshkin, Anjana Anand, Amanda Feeney, Sergio Gribaudo, Marie-Helene Baron, R Allerton, Hein Putter, Colin D. Johnson, P. Symonds, Ina M. Jürgenliemk-Schulz, Romerai D'Amico, Ilka Kolodziej, M Adusumalli, Naveena Singh, G Artioli, An Snyers, R Wade, Christine Haie-Meder, Roldano Fossati, Nicole Tubiana-Mathieu, Anthony Fyles, Silvestro Carinelli, Anne Capp, Alexandra J. Stewart, Kaj De Winter, B. van Triest, L.C.H.W. Lutgens, Susan Brooks, E. Van der Steen-Banasik, Pierre Duvillard, Pvc Rittenberg, Alessandro Colombo
Publikováno v: Lancet Oncology, 20, 1273-1285
Lancet oncology, 20(9), 1273-1285. Elsevier Science
The Lancet Oncology, 20(9), 1273-1285
PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X
The Lancet Oncology
Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC
Lancet Oncology, 20, 9, pp. 1273-1285
BACKGROUND:The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer. We updated the analysis to investigate patterns of recurrence and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce8413d15fc6d6dd5eb177cabf60ffef
https://hdl.handle.net/2066/208651
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje